TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 92 filers reported holding TANGO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,615,596 | +52.7% | 143,481 | -55.0% | 0.01% | +66.7% |
Q2 2023 | $1,058,336 | -33.9% | 318,776 | -21.4% | 0.01% | -40.0% |
Q1 2023 | $1,601,982 | -36.2% | 405,565 | +17.1% | 0.01% | -41.2% |
Q4 2022 | $2,511,915 | +100.6% | 346,471 | +0.2% | 0.02% | +70.0% |
Q3 2022 | $1,252,000 | – | 345,923 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $218,038,359 | 82.15% |
Nextech Invest Ltd. | 5,533,980 | $62,312,615 | 18.88% |
Boxer Capital, LLC | 7,123,642 | $80,212,209 | 4.27% |
Bain Capital Life Sciences Investors, LLC | 2,892,663 | $32,571,385 | 3.64% |
EcoR1 Capital, LLC | 8,721,636 | $98,205,621 | 3.31% |
Samsara BioCapital, LLC | 630,000 | $7,093,800 | 2.17% |
Soleus Capital Management, L.P. | 1,929,019 | $21,720,754 | 2.00% |
Casdin Capital, LLC | 1,307,349 | $14,720,750 | 1.63% |
Southpoint Capital Advisors LP | 5,276,699 | $59,415,631 | 1.33% |
Affinity Asset Advisors, LLC | 350,000 | $3,941,000 | 1.11% |